| Ignatius Nyatsanza, MD | |
|
4401 S Western Ave, Oklahoma City, OK 73109-3413 | |
| (405) 713-7403 | |
| (405) 713-2794 |
| Full Name | Ignatius Nyatsanza |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 20 Years |
| Location | 4401 S Western Ave, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891945184 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 036137514 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Trinity Hospital | Chicago, IL | Hospital |
| Advocate Christ Hospital & Medical Center | Oak lawn, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing new drugs for the treatment of unmet medical needs, announced today that it has begun to enroll patients in a Phase I/II clinical trial of its lead drug candidate trans sodium crocetinate (TSC).
The World Health Organization (WHO) has created a list of health threats for the New Year. Interestingly, Anti-vaccination movement has featured among the top threats to the world. The anti-vaccination movement comprises of a group of people who are reluctant to getting vaccinated and refuse to vaccinate themselves or their children against vaccine preventable infections.
Uncovering the genetic makeup of patients using DNA sequencing has in recent years provided physicians and their patients with a greater understanding of how best to diagnose and treat the diseases that plague humanity. This is the essence of precision medicine.
The International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS), have proposed a new sub-classification of lung adenocarcinomas.
Memorial Sloan-Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features such as embargoed content for registered users and "trending topics" - a continually updated listing of story ideas and available experts to comment on the latest health news headlines.
› Verified 1 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing new drugs for the treatment of unmet medical needs, announced today that it has begun to enroll patients in a Phase I/II clinical trial of its lead drug candidate trans sodium crocetinate (TSC).
The World Health Organization (WHO) has created a list of health threats for the New Year. Interestingly, Anti-vaccination movement has featured among the top threats to the world. The anti-vaccination movement comprises of a group of people who are reluctant to getting vaccinated and refuse to vaccinate themselves or their children against vaccine preventable infections.
Uncovering the genetic makeup of patients using DNA sequencing has in recent years provided physicians and their patients with a greater understanding of how best to diagnose and treat the diseases that plague humanity. This is the essence of precision medicine.
The International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS), have proposed a new sub-classification of lung adenocarcinomas.
Memorial Sloan-Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features such as embargoed content for registered users and "trending topics" - a continually updated listing of story ideas and available experts to comment on the latest health news headlines.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ignatius Nyatsanza, MD Division Of Hematology Oncology, 840 S Wood St Ste 820-e Csb Mc 713, Chicago, IL 60612 Ph: (312) 996-9424 | Ignatius Nyatsanza, MD 4401 S Western Ave, Oklahoma City, OK 73109-3413 Ph: (405) 713-7403 |
News Archive
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing new drugs for the treatment of unmet medical needs, announced today that it has begun to enroll patients in a Phase I/II clinical trial of its lead drug candidate trans sodium crocetinate (TSC).
The World Health Organization (WHO) has created a list of health threats for the New Year. Interestingly, Anti-vaccination movement has featured among the top threats to the world. The anti-vaccination movement comprises of a group of people who are reluctant to getting vaccinated and refuse to vaccinate themselves or their children against vaccine preventable infections.
Uncovering the genetic makeup of patients using DNA sequencing has in recent years provided physicians and their patients with a greater understanding of how best to diagnose and treat the diseases that plague humanity. This is the essence of precision medicine.
The International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS), have proposed a new sub-classification of lung adenocarcinomas.
Memorial Sloan-Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features such as embargoed content for registered users and "trending topics" - a continually updated listing of story ideas and available experts to comment on the latest health news headlines.
› Verified 1 days ago
Evelyn Lorents, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |